Veracyte Inc

Common Name

Veracyte

Country

United States

Sector

Healthcare

Industry

Diagnostics & Research

Employees

824

Ticker

VCYT

Exchange

NASDAQ/NMS

Website

www.veracyte.com

Description

Veracyte Inc. is a genomic diagnostics company specializing in advanced molecular diagnostic tests that address critical healthcare needs. The primary function of Veracyte is to improve patient outcom... Show more

Financial Statements of Veracyte

Below are the financial statements of Veracyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023	2022
Revenue	—	—	—
Testing revenue	418.96^a	326.54^a	250.54^a
Product revenue	13.65^a	15.59^a	12.63^a
Biopharmaceutical and other revenue	13.15^a	18.92^a	33.36^a
Total revenue	445.76^a	361.05^a	296.54^a
Cost of revenue	—	—	—
Cost of testing revenue	-114.57^a	-88.91^a	-75.32^a
Cost of product revenue	-9.11^a	-8.67^a	-7.82^a
Cost of biopharmaceutical and other revenue	-12.38^a	-15.32^a	-18.45^a
Intangible asset amortization - cost of revenue	-11.55^a	-18.46^a	-19.27^a
Total cost of revenue	-147.62^a	-131.37^a	-120.86^a
Gross profit	298.15^a	229.68^a	175.68^a
Operating expenses	—	—	—
Research and development	-69.29^a	-57.31^a	-40.6^a
Selling and marketing	-95.43^a	-101.49^a	-97.56^a
General and administrative	-110.61^a	-86.23^a	-73.2^a
Impairment of long-lived assets	-3.37^a	-68.35^a	-3.32^a
Intangible asset amortization - operating expenses	-3.3^a	-2.11^a	-2.08^a
Total operating expenses	-282^a	-315.48^a	-216.76^a
Income (loss) from operations	16.14^a	-85.8^a	-41.08^a
Other income, net	9.6^a	9.18^a	4.65^a
Income (loss) before income taxes	25.74^a	-76.61^a	-36.43^a
Income tax provision (benefit)	-1.61^a	-2.21^a	-0.13^a
Net income (loss)	24.14^a	-74.4^a	-36.56^a

Verified Sources Behind Veracyte’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Veracyte’s data sources below and access millions more through our Disclosure Search.

a. Veracyte's 10-K 2024

Trace every data point back to Veracyte’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Veracyte Inc

Financial Statements of Veracyte

Verified Sources Behind Veracyte’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Charles River Laboratories International Inc

Revvity Inc

Quest Diagnostics Inc

Guardant Health Inc

Danaher Corp

Laboratory Corporation of America Holdings